Treatment-Resistant Depression
When two or more antidepressants have not provided relief, neurotherapy may open a pathway forward.
TMS and tDCS have demonstrated meaningful efficacy in patients with treatment-resistant depression, working directly at the neural circuits involved in mood regulation — without systemic side effects. Clinical outcomes show significant improvement in a majority of patients who have not responded to pharmacotherapy alone.
Learn more